1. Home
  2. CRVL vs XENE Comparison

CRVL vs XENE Comparison

Compare CRVL & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorVel Corp.

CRVL

CorVel Corp.

HOLD

Current Price

$70.02

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$43.42

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVL
XENE
Founded
1987
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.4B
IPO Year
1991
2014

Fundamental Metrics

Financial Performance
Metric
CRVL
XENE
Price
$70.02
$43.42
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$53.91
AVG Volume (30 Days)
177.8K
793.2K
Earning Date
02-03-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
28.11
N/A
EPS
2.02
N/A
Revenue
$933,841,000.00
$7,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.62
N/A
Revenue Growth
10.43
N/A
52 Week Low
$66.49
$26.74
52 Week High
$128.61
$46.60

Technical Indicators

Market Signals
Indicator
CRVL
XENE
Relative Strength Index (RSI) 44.97 54.58
Support Level $69.41 $42.89
Resistance Level $71.30 $44.57
Average True Range (ATR) 1.92 1.34
MACD 0.07 -0.12
Stochastic Oscillator 45.52 25.32

Price Performance

Historical Comparison
CRVL
XENE

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: